ÿÄêµÄ5ÔÂ19ÈÕÊÇÌìÏÂÑ×Ö¢ÐÔ³¦²¡ÈÕ£¬ÈÃÎÒÃÇÒ»Æð¹Ø×¢ÕâÖÖ²»¿ÉÖÎÓú¡¢ÐèÒªºã¾ÃÖÎÁƵļ²²¡¡£
Ñ×Ö¢ÐÔ³¦²¡ÈÅÂÒ»¼ÕßÕý³£ÉúÑÄ Ñ×Ö¢ÐÔ³¦²¡£¨Inflammatory Bowel Disease, IBD£©ÊÇÒ»ÖÖÂýÐÔ¡¢·ÇÌØÒìÐԵij¦µÀÑ×Ö¢ÐÔ¼²²¡£¬Ö÷Òª°üÀ¨¿ËÂÞ¶÷²¡£¨Crohn¡¯s Disease, CD£©ºÍÀ£ÑñÐԽ᳦Ñ×£¨Ulcerative Colitis, UC£©Á½Àà¡£ ¾ÝÈ«ÇòÎÀÉú×éÖ¯£¨WHO£©Êý¾ÝÏÔʾ£¬IBDÔÚÅ¹ú¼ÒÖеķ¢²¡Âʽϸߣ¬Ïà±È֮ϣ¬Éú³¤Öйú¼ÒµÄ²¡Àý½ÏÉÙ¡£µ«ÖµµÃ×¢ÖØµÄÊÇ£¬½üÄêÀ´£¬Ëæ×ÅÉúÑÄ·½·¨¡¢Òûʳ½á¹¹¼°ÇéÐÎÒòËØµÄת±ä£¬Éú³¤Öйú¼ÒµÄIBD»¼²¡ÂÊÒ²³ÊÉÏÉýÇ÷ÊÆ¡£ ¿ËÂÞ¶÷²¡¿ÉÓ°ÏìËùÓÐÄêËê¶ÎÈËȺ£¬µ«Í¨³£ÔÚ¶ùͯºÍÄêÇáÈË£¨10¡ª30Ë꣩ʱÆÚÊ״ηºÆð¡£À£ÑñÐԽ᳦Ñ׸üÇãÏòÓÚÈÅÂÒÄêÇá³ÉÈË£¨15Ëꡪ30Ë꣩ºÍÖÐÍíÄêȺÌ壨50Ëꡪ70Ë꣩£¬ÔÚ¶ùͯÖеı¬·¢ÂʵÍÓÚ¿ËÂÞ¶÷²¡¡£ ƵÈÔµÄÈç²ÞÐèÇó¡¢Ìض¨Ê³Îï²»ÄÍÊÜ¡¢ÌåÖØÏ½µ¡¢ÑªÐé¼°Ò»Á¬Æ£À͵ÈÖ¢×´ÑÏÖØÏÞÖÆÁËIBD»¼ÕßµÄÌåÁ¦ºÍ»î¶¯ÄÜÁ¦£¬½ø¶øÓ°Ïìµ½Éç½»»¥¶¯ºÍÖ°ÒµÉú³¤£¬µ¼Ö»¼ÕßÔâÊÜÖØ´óµÄÐÄÀí¼°ÐÄÀíѹÁ¦¡£
Ñ×Ö¢ÐÔ³¦²¡ÉÐÎÞ·¨¸ùÖÎ Ö»¹ÜIBDÏÖÔÚÉÐÎÞ¸ùÖÎÖ®·¨£¬µ«ÏÖ´úÒ½ÁÆÄÜ×ÊÖú»¼Õß»º½âÖ¢×´£¬ÖÎÁÆÖ¼Ôڸ濢ÁÙ´²»º½âÓ볦µÀð¤Ä¤ÓúºÏ£¬Í¬Ê±¿ØÖƲ¢·¢Ö¢¡¢¼õ»º²¡ÇéÏ£Íû£¬²¢Î¬³Öºã¾ÃÎȹ̡£ÖÎÁÆÊֶΰüÀ¨Ò©ÎïÖÎÁÆ¡¢¸öÐÔ»¯ÓªÑøÍýÏë¡¢ÐëҪʱµÄÊÖÊõ½éÈ룬ÒÔ¼°ÉúÑÄ·½·¨µ÷½âµÈ¶àÔª»¯Õ½ÂÔ¡£ ¡¶Ñ×Ö¢ÐÔ³¦²¡Õï¶ÏÓëÖÎÁƵĹ²Ê¶Òâ¼û¡·ÖÐÇ¿µ÷£¬ÒÀ¾Ý»¼ÕßÏêϸ²¡Ç鶍֯¼Æ»®¡£ÁÙ´²Ò½Éú»á˼Á¿¼²²¡»î¶¯¶È¡¢²¡±ä¹æÄ£¼°ÀàÐÍ£¨¿ËÂÞ¶÷²¡»òÀ£ÑñÐԽ᳦Ñ×£©£¬À´¾«×¼Ñ¡ÔñÖÎÁÆ·½·¨¡£Òò´Ë£¬°´ÆÚÆÀ¹À²¡Ç飬ÎÞаµ÷½âÖÎÁÆ£¬¹ØÓÚά³ÖIBDÖÎÁÆÐ§¹ûºÍÔ¤·À¸´·¢ÖÁ¹ØÖ÷Òª¡£
ANCAºÍASCAÊǸ¨ÖúÕï¶ÏIBDµÄÒªº¦Ö¸±ê IBDµÄÕï¶Ïȱ·¦¼òµ¥½ð±ê×¼£¬ÐèÒª×ÛºÏÁÙ´²ÌåÏÖ¡¢ÊµÑéÊÒ¼ì²é¡¢Ó°Ïñѧ¡¢ÄÚ¾µ¼ì²éºÍ×éÖ¯²¡ÀíѧЧ¹û¡£Í¬Ê±£¬ÎªÁË×¼È·Çø·ÖIBDÓëÆäËûÀàËÆ¼²²¡£¬ÈçѬȾÐÔ³¦Ñ×»ò³¦½áºË£¬ÅбðÕï¶ÏÊDZز»¿ÉÉٵİ취¡£ ½üÄêÀ´£¬ÑªÇåѧ±ê¼ÇÎï¼ì²âÒÔÆäÇáÓ¯¡¢ÎÞÍ´¡¢»¼ÕßÒ×½ÓÊܵÄÌØµã£¬³ÉΪ¸¨ÖúÕï¶ÏµÄÖ÷Òª¹¤¾ß£¬ÓÈÆäÔÚÁÙ´²ÌåÏÖ²»µä·¶µÄÇéÐÎÏ¡£ÆäÖУ¬Á½Ïî±ê¼ÇÎ¡ª¿¹ÖÐÐÔÁ£Ï¸°û°û½¬¿¹Ì壨ANCA£©ºÍ¿¹Äð¾Æ½Íĸ¿¹Ì壨ASCA£©¡ª¡ªÒѱ»ÌìÏÂ賦×éÖ¯ÈϿɣ¬×÷Ϊ¸¨ÖúÕï¶ÏIBDµÄÖ¸±ê¡£ ANCA³£ÓëÀ£ÑñÐԽ᳦Ñ×£¨UC£©¹ØÁª£¬Ñо¿ÏÔʾ£¬UC»¼ÕßÖÐANCAÑôÐÔÂʸߴï40%ÖÁ85%£¬¶ø¿ËÂÞ¶÷²¡£¨CD£©»¼Õß½ö5%ÖÁ10%£¬¿µ½¡ÈËÔò¸üµÍ¡£×÷ΪUCµÄ¸¨ÖúÕï¶Ï¹¤¾ß£¬ANCAÕ¹ÏÖ³öÁË50.4%µÄÕï¶ÏÃô¸Ð¶ÈºÍ94.4%µÄÌØÒì¶È[3]¡£ ASCAÓë¿ËÂÞ¶÷²¡¹ØÏµ¸üÇ×½ü£¬Ô¼50%ÖÁ65%µÄCD»¼Õß³ÊÑôÐÔ£¬¶øUC»¼ÕßÑôÐÔÂʽö6%ÖÁ12%¡£ASCAÔÚCDÕï¶ÏÖеÄÃô¸Ð¶ÈΪ34.7%£¬ÌØÒì¶È´ï89.7%[3]£¬ÊǸ¨ÖúÇø·ÖUCºÍCDµÄÓÐÁ¦ÖúÊÖ¡£
¡°¾«×¼ÕïÁÆ£«¿ÆÑ§¹ÜÀí¡±Ó¦¶ÔIBD´øÀ´µÄºã¾Ã¿µ½¡ÌôÕ½
Ó¦¶ÔIBD´øÀ´µÄºã¾Ã¿µ½¡ÌôÕ½£¬¾«×¼Õï¶ÏÊÇÓÐÓÃÖÎÁƵÄÌõ¼þ¡£mg±ùÇòÍ»ÆÆ¹ÙÍøÍøÕ¾ÌṩÁ˶àÏîÕë¶ÔÐԵļì²â·þÎñ£¬×ÊÖúÁÙ´²Ò½Éú¸ü׼ȷµØÕÆÎÕ»¼Õß²¡Ç飬ΪºóÐøÖÎÁÆÌṩ¿ÆÑ§ÒÀ¾Ý¡£
¿¹ÖÐÐÔÁ£Ï¸°û°û½¬¿¹ÌåÁ½Ïî
°üÀ¨p-ANCAºÍc-ANCA£¬¶ÔÅбðÕï¶ÏUCµÈÓÐÖ÷Òª¼ÛÖµ¡£
賦µÀ²¡×ÔÉí¿¹ÌåÎåÏî
º¸ÇASCA¡¢¿¹Âó½ºÂѰ׿¹Ì壨AGA£©¡¢¿¹×éÖ¯Ð͹Ȱ±Ëá°·×ªÒÆÃ¸¿¹Ì壨tTG£©¡¢¿¹ÄÚÒò×Ó¿¹Ì壨IFA£©¡¢¿¹±Úϸ°û¿¹Ì壨PCA£©£¬ÆÕ±éÓ¦ÓÃÓÚIBD¼°ÆäËû賦µÀ¼²²¡µÄÅбðÓë¼à²â¡£
ͬʱ£¬Æð¾¢µÄÉúÑÄ̬¶ÈºÍ¿ÆÑ§¹ÜÀí£¬Ò²ÄÜ×ÊÖú»¼Õ߸ÄÉÆÉúÑÄÖÊÁ¿¡£ ×ñÕÕÒ½Öö£ºÑϿᰴҽÉúÖ¸µ¼ÓÃÒ©£¬²»ËæÒâ±ä»»ÖÎÁƼƻ®¡£ Òûʳ¹ÜÀí£ºÓëÓªÑøÊ¦ºÏ×÷£¬¶¨ÖƸöÐÔ»¯Òûʳ£¬×¢ÖØÊ³Îï²»ÄÍÊÜɸ²é¡£ ÐÄÀíÓëÔ˶¯£º¼á³ÖÁ¼Ê¢Òâ̬£¬ÊÊÁ¿Ô˶¯£¬ÔöÇ¿ÉíÌå¶Ô¿¹Á¦¡£ °´ÆÚËæ·Ã£ºÓëÒ½Éú¼á³ÖÏàͬ£¬¼ÓÈ뻼Õß½ÌÓý»î¶¯£¬Ç×½ü¼à²â²¡Çéת±ä¡£
²Î¿¼ÎÄÏ× [1] Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R, Fedail S, Gearry R, Goh KL, Hamid S, Khan AG. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis. 2010;16:112-124 [2] Ñ×Ö¢ÐÔ³¦²¡Õï¶ÏÓëÖÎÁƵĹ²Ê¶Òâ¼û£¨2018Äꡤ±±¾©£©ÖлªÑ×ÐÔ³¦²¡ÔÓÖ¾ 2018 Äê 7 ÔÂµÚ 2 ¾íµÚ 3 ÆÚ Chin J Inflamm Bowel Dis£¬July 2018£¬Vol.2£¬No.3 [3] ÌÆò«,Ì·Ýí,Éò±ù±ù,µÈ. ²î±ðѪÇåѧ±ê¼ÇÎïÔÚÑ×Ö¢ÐÔ³¦²¡ÖеÄÕï¶Ï¼ÛÖµÒÔ¼°Óë¼²²¡±íÐ͵ĹØÁªÆÊÎö[J]. ÖлªÒ½Ñ§ÔÓÖ¾,2022,102(47):3743-3748.